e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Regulation of allergic airway inflammation in animal models of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The anti-inflammatory effects of angiopoietin-1 in mice asthma
D. Simoes, T. Vassilakopoulos, K. Petrochilou, C. Roussos, A. Papapetropoulos (Athens, Patras, Greece)
Source:
Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Session:
Regulation of allergic airway inflammation in animal models of asthma
Session type:
Oral Presentation
Number:
4014
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Simoes, T. Vassilakopoulos, K. Petrochilou, C. Roussos, A. Papapetropoulos (Athens, Patras, Greece). The anti-inflammatory effects of angiopoietin-1 in mice asthma. Eur Respir J 2007; 30: Suppl. 51, 4014
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008
Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma
Source: Annual Congress 2009 - Novel approaches in asthma
Year: 2009
Ovalbumin-induced asthma model in Brown Norway rats demonstrates potential anti-asthmatic effects of Neu-164, a novel antioxidant and anti-inflammatory compound
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008
HDAC2-independent anti-inflammatory effects of budesonide in human lung fibroblasts
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002
Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma?
Source: Eur Respir J 2001; 17: 1059-1061
Year: 2001
Dose-dependent effects of muIL-13Rα2, a potent IL-13 neutraliser, on the phenotype of an acute allergic airways inflammation model in BALB/c mice
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004
Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2008 - Airway cell biology
Year: 2008
The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Local and systemic imbalance of pro- and antiinflammatory cytokines in COPD
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
IL-37 ameliorates experimental asthma by inhibiting IL-1
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003
The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Antitussive and antiinflammatory effect of montelukast in patients with cough variant asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 440s
Year: 2006
The effects of intra-nasally administered anti-inflammatory compounds in a mouse model of acute COPD exacerbations
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept